Exane Derivatives’s Alto Ingredients ALTO Stock Holding History

Exane Derivatives’s Portfolio ALTO Stock Details ALTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$7	–	631
2017 Q1	$7	Sell	1 -6	-86%	-$46	﹤0.01%	561
2016 Q4	$66	Hold	7	–	–	﹤0.01%	564
2016 Q3	$48	Hold	7	–	–	﹤0.01%	562
2016 Q2	$38	Hold	7	–	–	﹤0.01%	505
2016 Q1	$33	Hold	7	–	–	﹤0.01%	562
2015 Q4	$33	Hold	7	–	–	﹤0.01%	476
2015 Q3	$45	Hold	7	–	–	﹤0.01%	506
2015 Q2	$72	Hold	7	–	–	﹤0.01%	499
2015 Q1	$76	Hold	7	–	–	﹤0.01%	495
2014 Q4	$72	Buy	+7	New	+$85	﹤0.01%	505

Other funds holding ALTO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIG

Candlewood Investment Group Rye, New York $10.1M AUM 30% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Exane Derivatives's ALTO Position: Q2 2017 in Review

Exane Derivatives sold out of Alto Ingredients (ALTO) in Q2 2017, closing a stake of 1 share — an estimated $7 sold.

Exane Derivatives first reported a position in ALTO in Q4 2014 and held it in 10 quarters. The position peaked at $76 in Q1 2015. 124 funds tracked by Wall St. Rank hold ALTO as of Q2 2017.

Exane Derivatives reported no remaining Alto Ingredients position as of Q2 2017 after selling out during the quarter.
Exane Derivatives sold 1 Alto Ingredients share in Q2 2017, an estimated $7.
Exane Derivatives first reported a position in Alto Ingredients in Q4 2014 and held it in 10 quarters.
Exane Derivatives's Alto Ingredients position peaked at $76 in Q1 2015.
124 funds tracked by Wall St. Rank held Alto Ingredients as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.